These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 18854728)

  • 1. Absorption of brimonidine 0.1% and 0.15% ophthalmic solutions in the aqueous humor of cataract patients.
    Cantor LB; WuDunn D; Catoira-Boyle Y; Yung CW
    J Glaucoma; 2008; 17(7):529-34. PubMed ID: 18854728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation effects on ocular absorption of brimonidine in rabbit eyes.
    Acheampong AA; Small D; Baumgarten V; Welty D; Tang-Liu D
    J Ocul Pharmacol Ther; 2002 Aug; 18(4):325-37. PubMed ID: 12222763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fourth-generation fluoroquinolone penetration into the aqueous humor in humans.
    McCulley JP; Caudle D; Aronowicz JD; Shine WE
    Ophthalmology; 2006 Jun; 113(6):955-9. PubMed ID: 16603244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative ocular pharmacokinetics of brimonidine after a single dose application to the eyes of albino and pigmented rabbits.
    Acheampong AA; Shackleton M; Tang-Liu DD
    Drug Metab Dispos; 1995 Jul; 23(7):708-12. PubMed ID: 7587958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aqueous penetration and biological activity of moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% solution in cataract surgery patients.
    Kim DH; Stark WJ; O'Brien TP; Dick JD
    Ophthalmology; 2005 Nov; 112(11):1992-6. PubMed ID: 16183125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of ketorolac 0.4% and bromfenac 0.09% at trough dosing: aqueous drug absorption and prostaglandin E2 levels.
    Bucci FA; Waterbury LD
    J Cataract Refract Surg; 2008 Sep; 34(9):1509-12. PubMed ID: 18721711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of 2 moxifloxacin regimens for preoperative prophylaxis: prospective randomized triple-masked trial. Part 1: aqueous concentration of moxifloxacin.
    Vasavada AR; Gajjar D; Raj SM; Vasavada V; Vasavada V
    J Cataract Refract Surg; 2008 Aug; 34(8):1379-82. PubMed ID: 18655991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capillary electrophoretic analysis of brimonidine in aqueous humor of the eye and blood sera and relation of its levels with intraocular pressure.
    Tzovolou DN; Lamari F; Mela EK; Gartaganis SP; Karamanos NK
    Biomed Chromatogr; 2000 Aug; 14(5):301-5. PubMed ID: 10960828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flomoxef sodium and levofloxacin concentrations in aqueous humor.
    Mizuki N; Watanabe Y; Miyamoto M; Iijima Y; Takiyama N; Ito Y; Ito N; Nishida T; Iwata S; Endo Y; Ito D
    Ocul Immunol Inflamm; 2005; 13(2-3):229-34. PubMed ID: 16019684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aqueous penetration of moxifloxacin 0.5% ophthalmic solution and besifloxacin 0.6% ophthalmic suspension in cataract surgery patients.
    Yoshida J; Kim A; Pratzer KA; Stark WJ
    J Cataract Refract Surg; 2010 Sep; 36(9):1499-502. PubMed ID: 20692561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the preservative purite on the bioavailability of brimonidine in the aqueous humor of rabbits.
    Dong JQ; Babusis DM; Welty DF; Acheampong AA; Tang-Liu D; Whitcup SM
    J Ocul Pharmacol Ther; 2004 Aug; 20(4):285-92. PubMed ID: 15321023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitreous and aqueous concentrations of brimonidine following topical application of brimonidine tartrate 0.1% ophthalmic solution in humans.
    Takamura Y; Tomomatsu T; Matsumura T; Takihara Y; Kozai S; Arimura S; Yokota S; Inatani M
    J Ocul Pharmacol Ther; 2015 Jun; 31(5):282-5. PubMed ID: 25918904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An in vivo study comparing the ocular absorption of levofloxacin and ciprofloxacin prior to phacoemulsification.
    Bucci FA
    Am J Ophthalmol; 2004 Feb; 137(2):308-12. PubMed ID: 14962422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of drug concentration in aqueous humor of cataract patients administered gatifloxacin ophthalmic gel.
    Liu X; Wang NL; Wang YL; Ma C; Ma L; Gao LX; Huang YX; Xiong SH; Wang K
    Chin Med J (Engl); 2010 Aug; 123(15):2105-10. PubMed ID: 20819550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an HPLC method for determining the alpha 2-adrenergic receptor agonist brimonidine in blood serum and aqueous humor of the eye.
    Karamanos NK; Lamari F; Katsimpris J; Gartaganis S
    Biomed Chromatogr; 1999 Feb; 13(1):86-8. PubMed ID: 10191952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corneal penetration of fluoroquinolones: aqueous humor concentrations after topical application of levofloxacin 0.5% and ofloxacin 0.3% eyedrops.
    Koch HR; Kulus SC; Roessler M; Ropo A; Geldsetzer K
    J Cataract Refract Surg; 2005 Jul; 31(7):1377-85. PubMed ID: 16105610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of bimatoprost acid in the aqueous humour after bimatoprost treatment of patients with cataract.
    Cantor LB; Hoop J; Wudunn D; Yung CW; Catoira Y; Valluri S; Cortes A; Acheampong A; Woodward DF; Wheeler LA
    Br J Ophthalmol; 2007 May; 91(5):629-32. PubMed ID: 17135335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of brimonidine tartrate 0.15% on night-vision difficulty and contrast testing after refractive surgery.
    Edwards JD; Burka JM; Bower KS; Stutzman RD; Sediq DA; Rabin JC
    J Cataract Refract Surg; 2008 Sep; 34(9):1538-41. PubMed ID: 18721716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of brimonidine tartrate 0.2% ophthalmic solution on pupil size.
    Kesler A; Shemesh G; Rothkoff L; Lazar M
    J Cataract Refract Surg; 2004 Aug; 30(8):1707-10. PubMed ID: 15313294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics of 2% topical dorzolamide in the aqueous humor of humans.
    Schmitz K; Banditt P; Motschmann M; Meyer FP; Behrens-Baumann W
    Invest Ophthalmol Vis Sci; 1999 Jun; 40(7):1621-4. PubMed ID: 10359348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.